7 Stunden Primaerer Wirkort | Extrazellulare Matrix, Genexpression | Vaskulaere Signalwege, NO-System | Zytoskelett, Aktinpolymerisation Schluesselrezeptoren | TGF-beta, MMP/TIMP | VEGFR2, eNOS | G-Aktin, ILK-PI3K-Akt Forschungsschwerpunkt | Hautregeneration, Anti-Aging, Kollagen | Magen-Darm, Sehnen, Entzuendung | Gewebereparatur, Zellmigration Koerperidentisch | Ja (Plasmabestandteil) | Nein (synthetisch, aber aus Magensaft abgeleitet) | Ja (Thymosin-Beta-4-Fragment) Genmodulation | Ueber 4.000 Gene | Begrenzt dokumentiert | Moderat dokumentiert Welche Sicherheitsaspekte sind aus der Forschung bekannt
Pick a Lane The mistake most CPG brands make is thinking they just need to add protein to win
Functional Medicine Perspective From a functional medicine viewpoint, IGF-1 LR3 fits into a broader strategy for: Preserving muscle mass Supporting injury recovery Enhancing metabolic flexibility Countering age-related decline This approach combines peptide therapy with: Anti-inflammatory nutrition Resistance training Sleep optimization Micronutrient support Conclusion IGF-1 LR3 is a powerful, long-acting analog of insulin-like growth factor 1 that enhances recovery, stimulates muscle growth, and supports tissue repair far beyond the capacity of natural IGF-1 alone
Analogously, semaglutide protected diabetic cardiomyopathy mice against oxidative stress and apoptosis, and thereby improved cardiac dysfunction by activating Sirt1/AMPK pathway and restoring of Cx43 expression [108]